SOLV
What one share of Solventum holds
Surgical and Medical Instruments and Apparatus
Solventum Corporation ("Solventum," "we," "our," "us," or the "Company"), is a leading global healthcare company developing, manufacturing, and commercializing a broad portfolio of solutions that leverages deep material science, data science, and digital capabilities to address critical customer and patient needs.
Solventum’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $47.49 |
|---|---|
| Profit | $8.19 |
| Capex (buildings and equipment) | $1.87 |
| Free cash flow | −$0.67 |
| Cash and investments | $2.37 |
| Debt | $31.07 |
| Book value | $28.22 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2022 | $47.08 | $7.78 | $1.45 | $8.27 | — | $67.99 |
| 2023 | $47.46 | $7.79 | $1.68 | $9.41 | — | — |
| 2024 | $47.52 | $2.76 | $2.19 | $4.63 | — | $17.13 |
| 2025 | $47.49 | $8.88 | $2.16 | −$0.06 | — | $29.10 |